Introduction:
In Mexico, antiretroviral therapy (ART) coverage for human
immunodeficiency virus (HIV) infection is about 85%; the aim is to achieve
optimal and prolonged HIV-1 RNA viral load suppression, if possible to <50
copies/mL, and patient adherence is necessary . ART suppresses the HIV-1RNA viral load, leading to immunological recovery and clinical improvements . Success in achieving good outcomes relies on high levels of ART
adherence: preferably 95% or more to suppress HIV replication, and 80% or more
to protect the immune system.
The World Health Organization defines adherence as the
degree to which people’s behavior taking medication, keeping on a diet, and
changes in lifestyle corresponds with agreed recommendations from a health care
provider. Poor adherence compromises health improvements and leads to the
wastage of treatment resources that are already limited. Non-adherence to
recommended therapies is a global problem and has been observed for all
diseases, but adherence to ART differs among countries according to clinical,
economic, and socio-demographic factors. A meta-analysis of 19
case-controlled studies found that adherence to ART was significantly lower in
patients with adverse reactions to antiretroviral drugs than among those
without them.
A cross-sectional study conducted in Barcelona, Spain, in
2002 used the simplified medication adherence questionnaire (SMAQ) to validate
adherence and applied it to 3004 HIV-infected patients. The test consists of
six questions and the study found a prevalence of ART adherence of 68% in that
population . A study conducted in Mexico on 93 HIV-infected patients foundthat 43% of participants were nonadherent; however, factors associated with
nonadherence were not evaluated. In our country, information about ART
adherence, the impact that it has on HIV-infected patients, and the associated
risk factors is still limited. The aim of this study was to determine the
prevalence of ART adherence and the risk factors associated with nonadherence
in this HIV-infected population.
No comments:
Post a Comment